Mesoblast (MESO) Receivables (2015 - 2026)

Mesoblast has reported Receivables for 11 years, with the latest figure at $43.3 million in Q4 2025.

• Quarterly Receivables rose 106.66% year-over-year to $43.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $43.3 million (up 106.66% YoY) and the FY2025 annual result came in at $14.9 million, down 29.05% from the prior year.
• Receivables climbed to $43.3 million in Q4 2025 per MESO's latest filing, from $14.9 million in the prior quarter.
• Over five years, Receivables peaked at $43.3 million in Q4 2025 and troughed at $2.9 million in Q1 2021.
• A 5-year average of $10.4 million and a median of $5.6 million in 2022 frame the typical range for Receivables.
• The sharpest annual moves came in 2021 and 2022: Receivables surged 207.62% in 2021, then slumped 31.35% in 2022.
• Over 5 years, Receivables stood at $6.0 million in 2021, then declined by 27.2% to $4.4 million in 2022, then soared by 58.94% to $7.0 million in 2023, then surged by 199.4% to $21.0 million in 2024, then jumped by 106.66% to $43.3 million in 2025.
• According to Business Quant data, Receivables over the past three periods registered $43.3 million, $14.9 million, and $21.0 million for Q4 2025, Q2 2025, and Q4 2024 respectively.